NCAM2
Neural cell adhesion molecule 2
Also known as: MGC51008, NCAM2_HUMAN, NCAM21
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15394
- Gene
- NCAM2
- Ensembl
- ENSG00000154654
- Chromosome
- 21
- Canonical length
- 837 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Nuclear bodies,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene belongs to the immunoglobulin superfamily. It is a type I membrane protein and may function in selective fasciculation and zone-to-zone projection of the primary olfactory axons. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
837 residues, UniProt reviewed canonical sequence.
>O15394|NCAM2
1 MSLLLSFYLL GLLVSSGQAL LQVTISLSKV ELSVGESKFF TCTAIGEPES IDWYNPQGEK
61 IISTQRVVVQ KEGVRSRLTI YNANIEDAGI YRCQATDAKG QTQEATVVLE IYQKLTFREV
121 VSPQEFKQGE DAEVVCRVSS SPAPAVSWLY HNEEVTTISD NRFAMLANNN LQILNINKSD
181 EGIYRCEGRV EARGEIDFRD IIVIVNVPPA ISMPQKSFNA TAERGEEMTF SCRASGSPEP
241 AISWFRNGKL IEENEKYILK GSNTELTVRN IINSDGGPYV CRATNKAGED EKQAFLQVFV
301 QPHIIQLKNE TTYENGQVTL VCDAEGEPIP EITWKRAVDG FTFTEGDKSL DGRIEVKGQH
361 GSSSLHIKDV KLSDSGRYDC EAASRIGGHQ KSMYLDIEYA PKFISNQTIY YSWEGNPINI
421 SCDVKSNPPA SIHWRRDKLV LPAKNTTNLK TYSTGRKMIL EIAPTSDNDF GRYNCTATNH
481 IGTRFQEYIL ALADVPSSPY GVKIIELSQT TAKVSFNKPD SHGGVPIHHY QVDVKEVASE
541 IWKIVRSHGV QTMVVLNNLE PNTTYEIRVA AVNGKGQGDY SKIEIFQTLP VREPSPPSIH
601 GQPSSGKSFK LSITKQDDGG APILEYIVKY RSKDKEDQWL EKKVQGNKDH IILEHLQWTM
661 GYEVQITAAN RLGYSEPTVY EFSMPPKPNI IKDTLFNGLG LGAVIGLGVA ALLLILVVTD
721 VSCFFIRQCG LLMCITRRMC GKKSGSSGKS KELEEGKAAY LKDGSKEPIV EMRTEDERVT
781 NHEDGSPVNE PNETTPLTEP EKLPLKEEDG KEALNPETIE IKVSNDIIQS KEDDSKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCAM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 39 nTPM
- hippocampal formation: 13 nTPM
- amygdala: 13 nTPM
- adrenal gland: 11 nTPM
- hypothalamus: 11 nTPM
- basal ganglia: 9.8 nTPM
Single-cell type
- bergmann glia: 2,750 nCPM
- oligodendrocyte progenitor cells: 2,609 nCPM
- oligodendrocytes: 2,579 nCPM
- brain excitatory neurons: 1,376 nCPM
- sertoli cells: 1,315 nCPM
- schwann cells: 1,302 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 78 nTPM
- hippocampal formation: 69 nTPM
- white matter: 67 nTPM
- cerebral cortex: 64 nTPM
- basal ganglia: 63 nTPM
- midbrain: 54 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Neural cell adhesion
- Immunoglobulin I-set
- Immunoglobulin V-set domain
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Neural and epithelial cell adhesion domain-containing protein
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Immunoglobulin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCAM2 as an antibody target. Whether an autoantibody or antibody against NCAM2 could matter depends on whether native NCAM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCAM2 is annotated at the cell surface, where native NCAM2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NCAM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...